US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 4.830
- -0.170-3.40%
Close Nov 15 16:00 ET
- 4.630
- -0.200-4.14%
Post 16:25 ET
42.95MMarket Cap-80500P/E (TTM)
5.157High4.557Low7.51KVolume5.000Open5.000Pre Close36.69KTurnover0.26%Turnover RatioLossP/E (Static)8.89MShares22.82552wk High-3.12P/B14.14MFloat Cap3.81052wk Low--Dividend TTM2.93MShs Float209.262Historical High--Div YieldTTM12.00%Amplitude3.810Historical Low4.887Avg Price1Lot Size
Serina Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | -83.55%500K | 3.04M |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | -83.55%500K | --3.04M |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 263.09%5.31M | 309.10%3.87M | 141.27%2.32M | 1.46M | 945K | 962K | -40.69%2.77M | 4.67M |
| Selling and administrative expenses | 227.45%2.91M | 391.12%2.32M | 105.73%1.22M | --889K | --473K | --593K | -0.68%1.29M | --1.3M |
| -General and administrative expense | 227.45%2.91M | 391.12%2.32M | 105.73%1.22M | --889K | --473K | --593K | -0.68%1.29M | --1.3M |
| Research and development costs | 300.50%2.42M | 232.78%1.59M | 177.19%1.11M | --603K | --479K | --399K | -58.59%1.57M | --3.8M |
| Other operating expenses | 51.72%-14K | -628.57%-51K | 83.33%-5K | ---29K | ---7K | ---30K | 78.50%-91.5K | ---425.57K |
| Operating profit | -263.09%-5.31M | -309.10%-3.87M | -141.27%-2.32M | -1.46M | -945K | -962K | -39.16%-2.27M | -1.63M |
| Net non-operating interest income expense | 84.00%-16K | -124.07%-242K | -15.12%-99K | -100K | -108K | -86K | -281.85%-14.12K | 7.77K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | -83.82%1.76K | --10.86K |
| Non-operating interest expense | -84.00%16K | 124.07%242K | 15.12%99K | --100K | --108K | --86K | 413.19%15.88K | --3.09K |
| Other net income (expense) | 102.44%6.71M | 398.93%9.29M | -359.31%-7.02M | 3.32M | 1.86M | 2.71M | -210.75%-397.62K | 359.04K |
| Gain on sale of security | 107.76%6.67M | 399.41%9.29M | -359.31%-7.02M | --3.21M | --1.86M | --2.71M | -300.52%-398.7K | --198.84K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --160.21K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---187.13K |
| -Gain on sale of business | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---26.93K |
| Other non- operating income (expenses) | -60.00%42K | ---9K | ---- | --105K | ---- | ---- | --1.08K | ---- |
| Income before tax | -21.06%1.38M | 540.72%5.18M | -669.18%-9.44M | 1.75M | 808K | 1.66M | -112.07%-2.68M | -1.26M |
| Income tax | ||||||||
| Net income | -21.06%1.38M | 540.72%5.18M | -669.18%-9.44M | 1.75M | 808K | 1.66M | -112.07%-2.68M | -1.26M |
| Net income continuous Operations | -21.06%1.38M | 540.72%5.18M | -669.18%-9.44M | --1.75M | --808K | --1.66M | -112.07%-2.68M | ---1.26M |
| Minority interest income | -27K | -27K | 0 | 0 | ||||
| Net income attributable to the parent company | -19.52%1.41M | 544.06%5.2M | -669.18%-9.44M | 1.75M | 808K | 1.66M | -112.07%-2.68M | -1.26M |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | -19.52%1.41M | 544.06%5.2M | -669.18%-9.44M | 1.75M | 808K | 1.66M | -112.07%-2.68M | -1.26M |
| Basic earnings per share | -80.00%0.16 | 65.33%0.61 | -538.96%-3.38 | 0.8 | 0.369 | 0.77 | -112.07%-1.2326 | -0.5812 |
| Diluted earnings per share | -43.48%0.13 | 366.00%0.51 | -1,790.00%-3.38 | 0.23 | 0.1094 | 0.2 | -112.07%-1.2326 | -0.5812 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data